Governments And WHO Changed Covid-19 Policy Based on Suspect Data From Tiny US Company

Comment: The outfit that somehow got the ears of the WHO and every major world nation, appears to have been a dodgy front operation for something else, and was used to destroy the credibility of hydroxychloroquine as an effective treatment for covid-19. In short, it seems someone with a lot of influence really wanted to prevent the widespread acceptance of an effective treatment for Covid-19 (looking at you, Big Pharma).

Dr. Mandeep Mehra, the lead co-author of the dodgy study, is a director at Brigham & Women’s Hospital, which is credited with providing funding. Dr. Mehra and The Lancet failed to disclose that Brigham Hospital has a partnership with Gilead and is currently conducting TWO trials testing the drug Remdesivir, the prime competitor of hydroxychloroquine for the treatment of COVID-19, the focus of the study….

https://www.sott.net/article/435647-Governments-And-WHO-Changed-Covid-19-Policy-Based-on-Suspect-Data-From-Tiny-US-Company

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.